Our second webinar took place on Thursday 20th September 2018. Chaired by Professor Patrick Brundin, the panel discussed Per Borghammer’s paper “How Does Parkinson’s Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology” (click here for PM summary).
The inaugural webinar discussion led by Chair Professor Patrick Brundin examined the paper “What effects might exenatide have on non-motor symptoms in Parkinson’s disease: A post hoc analysis”, by Dr Dilan Athauda et al (read our PM summary here).
Professor Brundin was joined by fellow panellists Professor Tom Foltynie from University College London (UCL), who led the exenatide trial, Nigel Greig and Dimitrios Kapogiannis from the National Institute of Ageing (NIA), and exenatide trial participant Penny Kustow.